These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19223175)

  • 1. Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent.
    Lorusso G; Vannini N; Sogno I; Generoso L; Garbisa S; Noonan DM; Albini A
    Eur J Cancer; 2009 May; 45(8):1474-84. PubMed ID: 19223175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
    Martínez-Poveda B; Quesada AR; Medina MA
    Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin acts as an angiogenesis inhibitor.
    Schempp CM; Kiss J; Kirkin V; Averbeck M; Simon-Haarhaus B; Kremer B; Termeer CC; Sleeman J; Simon JC
    Planta Med; 2005 Nov; 71(11):999-1004. PubMed ID: 16320199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
    Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA
    PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin.
    Cervo L; Mennini T; Rozio M; Ekalle-Soppo CB; Canetta A; Burbassi S; Guiso G; Pirona L; Riva A; Morazzoni P; Caccia S; Gobbi M
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):211-8. PubMed ID: 15695067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.
    Rothley M; Schmid A; Thiele W; Schacht V; Plaumann D; Gartner M; Yektaoglu A; Bruyère F; Noël A; Giannis A; Sleeman JP
    Int J Cancer; 2009 Jul; 125(1):34-42. PubMed ID: 19326439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the antileukemic activity of hyperforin.
    Billard C; Merhi F; Bauvois B
    Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.
    Dell'Aica I; Niero R; Piazza F; Cabrelle A; Sartor L; Colalto C; Brunetta E; Lorusso G; Benelli R; Albini A; Calabrese F; Agostini C; Garbisa S
    J Pharmacol Exp Ther; 2007 May; 321(2):492-500. PubMed ID: 17289834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperforin: more than an antidepressant bioactive compound?
    Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
    Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant hyperforin up-regulates VEGF in CNS tumour cells.
    Tassone E; Maran C; Masola V; Bradaschia A; Garbisa S; Onisto M
    Pharmacol Res; 2011 Jan; 63(1):37-43. PubMed ID: 20883786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease.
    Cabrelle A; Dell'Aica I; Melchiori L; Carraro S; Brunetta E; Niero R; Scquizzato E; D'Intino G; Calzà L; Garbisa S; Agostini C
    J Leukoc Biol; 2008 Jan; 83(1):212-9. PubMed ID: 17947392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.
    Sogno I; Vannini N; Lorusso G; Cammarota R; Noonan DM; Generoso L; Sporn MB; Albini A
    Recent Results Cancer Res; 2009; 181():209-12. PubMed ID: 19213570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
    Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
    Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
    Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
    Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
    Kiss J
    Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antidepressant mechanism of Hypericum perforatum.
    Mennini T; Gobbi M
    Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts.
    Cervo L; Rozio M; Ekalle-Soppo CB; Guiso G; Morazzoni P; Caccia S
    Psychopharmacology (Berl); 2002 Dec; 164(4):423-8. PubMed ID: 12457273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.